Syngenta Invests in Biognosys AG
Syngenta Ventures Pte Limited, member of the Syngenta Group, has closed a venture capital investment in the ETH spin-off Biognosys AG. Founded in 2008, Biognosys is leader in targeted proteomics mass spectrometry.
Bär & Karrer acted as legal advisor to Syngenta Ventures for the venture capital investment. The team included Christoph Neeracher, Michael Trippel (both M&A/VC), Markus Wang (IP) and Luca Jagmetti (M&A/VC).